Originally posted on Lobular Ireland :
ILC is a luminal breast cancer that mostly expresses oestrogen receptor (ER) and responds well to treatments targeting ER function. However, if these endocrine interventions cease to be successful, it is notoriously difficult to treat disseminated ILC. In contrast to most breast cancers, it is clear that ILC development, progression…